BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28370342)

  • 1. Bone Mineral Density Increases in Trans Persons After 1 Year of Hormonal Treatment: A Multicenter Prospective Observational Study.
    Wiepjes CM; Vlot MC; Klaver M; Nota NM; de Blok CJ; de Jongh RT; Lips P; Heijboer AC; Fisher AD; Schreiner T; T'Sjoen G; den Heijer M
    J Bone Miner Res; 2017 Jun; 32(6):1252-1260. PubMed ID: 28370342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents.
    Vlot MC; Klink DT; den Heijer M; Blankenstein MA; Rotteveel J; Heijboer AC
    Bone; 2017 Feb; 95():11-19. PubMed ID: 27845262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone Safety During the First Ten Years of Gender-Affirming Hormonal Treatment in Transwomen and Transmen.
    Wiepjes CM; de Jongh RT; de Blok CJ; Vlot MC; Lips P; Twisk JW; den Heijer M
    J Bone Miner Res; 2019 Mar; 34(3):447-454. PubMed ID: 30537188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Mineral Density in Transgender Individuals After Gonadectomy and Long-Term Gender-Affirming Hormonal Treatment.
    Dobrolińska M; van der Tuuk K; Vink P; van den Berg M; Schuringa A; Monroy-Gonzalez AG; García DV; Schultz WCMW; Slart RHJA
    J Sex Med; 2019 Sep; 16(9):1469-1477. PubMed ID: 31326306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender-Affirming Hormone Treatment Decreases Bone Turnover in Transwomen and Older Transmen.
    Vlot MC; Wiepjes CM; de Jongh RT; T'Sjoen G; Heijboer AC; den Heijer M
    J Bone Miner Res; 2019 Oct; 34(10):1862-1872. PubMed ID: 31099910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study.
    Klaver M; de Blok CJM; Wiepjes CM; Nota NM; Dekker MJHJ; de Mutsert R; Schreiner T; Fisher AD; T'Sjoen G; den Heijer M
    Eur J Endocrinol; 2018 Feb; 178(2):163-171. PubMed ID: 29183889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of monthly ibandronate in men with low bone density.
    Orwoll ES; Binkley NC; Lewiecki EM; Gruntmanis U; Fries MA; Dasic G
    Bone; 2010 Apr; 46(4):970-6. PubMed ID: 20060082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of estrogen therapy on bone mass in postmenopausal women with osteopenia].
    Insua A; Negri A; Zanchetta JR
    Medicina (B Aires); 1995; 55(5 Pt 1):408-14. PubMed ID: 8728770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of Vitamin D-Binding Protein, and Total, Bioavailable, and Free 25-Hydroxyvitamin D in Transgender People.
    Chen H; Wiepjes CM; van Schoor NM; Heijboer AC; de Jongh RT; den Heijer M; Lips P
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2728-2734. PubMed ID: 30785996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiometabolic Effects of Testosterone in Transmen and Estrogen Plus Cyproterone Acetate in Transwomen.
    van Velzen DM; Paldino A; Klaver M; Nota NM; Defreyne J; Hovingh GK; Thijs A; Simsek S; T'Sjoen G; den Heijer M
    J Clin Endocrinol Metab; 2019 Jun; 104(6):1937-1947. PubMed ID: 30602016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cross-sex hormone therapy on bone mineral density and body composition in transwomen.
    Fighera TM; da Silva E; Lindenau JD; Spritzer PM
    Clin Endocrinol (Oxf); 2018 Jun; 88(6):856-862. PubMed ID: 29630732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections.
    Harel Z; Johnson CC; Gold MA; Cromer B; Peterson E; Burkman R; Stager M; Brown R; Bruner A; Coupey S; Hertweck P; Bone H; Wolter K; Nelson A; Marshall S; Bachrach LK
    Contraception; 2010 Apr; 81(4):281-91. PubMed ID: 20227543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body composition, bone turnover, and bone mass in trans men during testosterone treatment: 1-year follow-up data from a prospective case-controlled study (ENIGI).
    Van Caenegem E; Wierckx K; Taes Y; Schreiner T; Vandewalle S; Toye K; Lapauw B; Kaufman JM; T'Sjoen G
    Eur J Endocrinol; 2015 Feb; 172(2):163-71. PubMed ID: 25550352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative effect of endogenous estradiol and androgens on menopausal bone loss: a longitudinal study.
    Guthrie JR; Lehert P; Dennerstein L; Burger HG; Ebeling PR; Wark JD
    Osteoporos Int; 2004 Nov; 15(11):881-6. PubMed ID: 15042284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative bone SPECT in young males with delayed puberty and hypogonadism: implications for treatment of low bone mineral density.
    Lubushitzky R; Front D; Iosilevsky G; Bettman L; Frenkel A; Kolodny GM; Israel O
    J Nucl Med; 1998 Jan; 39(1):104-7. PubMed ID: 9443746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Review of the Long-Term Effects of Transgender Hormone Therapy on Bone Markers and Bone Mineral Density and Their Potential Effects in Implant Therapy.
    Delgado-Ruiz R; Swanson P; Romanos G
    J Clin Med; 2019 Jun; 8(6):. PubMed ID: 31159456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of bone mineral density with hemoglobin and change in hemoglobin among older men and women: The Cardiovascular Health Study.
    Valderrábano RJ; Buzkova P; Chang PY; Zakai NA; Fink HA; Robbins JA; Lee JS; Wu JY;
    Bone; 2019 Mar; 120():321-326. PubMed ID: 30448304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Hormonal Treatment Affects Body Composition and Body Shape in Young Transgender Adolescents.
    Klaver M; de Mutsert R; Wiepjes CM; Twisk JWR; den Heijer M; Rotteveel J; Klink DT
    J Sex Med; 2018 Feb; 15(2):251-260. PubMed ID: 29425666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal and anthropometric predictors of bone mass in healthy elderly men: major effect of sex hormone binding globulin, parathyroid hormone and body weight.
    Martínez Díaz-Guerra G; Hawkins F; Rapado A; Ruiz Díaz MA; Díaz-Curiel M
    Osteoporos Int; 2001; 12(3):178-84. PubMed ID: 11315235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral density and bone turnover in relation to serum leptin, alpha-ketoglutarate and sex steroids in overweight and obese postmenopausal women.
    Filip R; Raszewski G
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):214-20. PubMed ID: 18547340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.